Skip to contentS
Sanara MedTech Inc.
S
SMTISanara MedTech Inc. Q4 2015 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$707.47K$707.47Kderived−2.7% vs Q4 2014 Net Income-$318.37K-$318.37KderivedN/M vs Q4 2014 EPS, diluted—
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Sanara MedTech Inc. · CIK 714256 · Engraved from SEC EDGAR
Not derived. Share counts vary by quarter.
Gross Profitderived$435,052−27.1% Operating Incomederived-$393,850— Operating Cash Flowderived-$203,118N/M Free Cash Flowderived-$203,118N/M Margins · derivedGross margin61.5%−20.6 pt vs Q4 2014
Operating margin-55.7%
Net margin-45.0%−29.8 pt vs Q4 2014
ended Dec 31, 2015 · filed Apr 14, 2016 · 105 d after period end